✦ LIBER ✦

Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study

✍ Scribed by Lasse Oikarinen; Markku S Nieminen; Lauri Toivonen; Matti Viitasalo; Kristian Wachtell; Vasilios Papademetriou; Sverker Jern; B.jörn Dahlöf; Richard B Devereux; Peter M Okin

Book ID: 117008695
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 108 KB
Volume: 145
Category: Article
ISSN: 1097-6744
DOI: 10.1016/s0002-8703(02)94785-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relation of echocardiographic left ventr

Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertropy in hypertensive patients: the LIFE study

✍ Peter M Okin; Richard B Devereux; Sverker Jern; Stevo Julius; Sverre E Kjeldsen; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Body Build and Risk of Cardiovascular Ev

Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy. The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Prognostic importance of hemoglobin in h

Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study

✍ Michael Hecht Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Richard B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 314 KB

Effects of losartan on cardiovascular mo

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Cost-effectiveness of losartan-based the

Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Relation of impaired left ventricular fi

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

✍ Kristian Wachtell; Vasilios Papademetriou; Gunnar Smith; Eva Gerdts; Björn Dahlö 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB